)
Palvella Therapeutics (PVLA) investor relations material
Palvella Therapeutics AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Opening remarks and agenda
Meeting conducted virtually to maximize stockholder participation and accessibility.
Agenda and rules of conduct were adopted and made available on the virtual meeting site.
Chairman, board members, and independent auditor were introduced; meeting officially called to order.
Board and executive committee updates
Quorum confirmed with proxies representing a majority of voting power received.
Notice of meeting and proxy materials were distributed to stockholders of record.
Shareholder proposals
Six proposals presented: election of three Class III directors, ratification of auditor, advisory vote on executive compensation, advisory vote on frequency of compensation votes, amendment to equity plan, and potential adjournment.
- QTORIN platform advances rare skin disease therapies, targeting multi-billion dollar orphan markets.PVLA
Goldman Sachs 47th Annual Global Healthcare Conference 20269 Jun 2026 - Positive Phase 3 data and $230M financing drive NDA submission and launch readiness in 2027.PVLA
Q1 20267 May 2026 - Key votes include director elections, auditor ratification, and an equity plan share increase.PVLA
Proxy filing30 Apr 2026 - Board recommends all proxy proposals, highlighting governance, compensation, and equity plan changes.PVLA
Proxy filing30 Apr 2026 - QTORIN rapamycin showed strong efficacy and safety in Phase 3 SELVA for microcystic LMs.PVLA
Study result13 Apr 2026 - Positive Phase III data, pipeline growth, and $230M financing support 2026–27 milestones.PVLA
Q4 20256 Apr 2026 - QTORIN™ rapamycin achieved strong Phase 3 results in mLM, targeting a multi-billion dollar rare disease market.PVLA
Corporate presentation2 Apr 2026 - Merger forms a Nasdaq-listed rare disease biopharma with $80.5M cash and late-stage assets.PVLA
M&A Announcement3 Feb 2026 - Up to $300M in securities to advance rare skin disease therapies, backed by positive clinical data.PVLA
Registration Filing3 Jan 2026
Next Palvella Therapeutics earnings date
Next Palvella Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage